Passage Bio Inc. (PASG)
Passage Bio Statistics
Share Statistics
Passage Bio has 62.15M shares outstanding. The number of shares has increased by 0.82% in one year.
| Shares Outstanding | 62.15M |
| Shares Change (YoY) | 0.82% |
| Shares Change (QoQ) | 0.62% |
| Owned by Institutions (%) | 60.93% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 4,735 |
| FTD / Avg. Volume | 2.76% |
Short Selling Information
The latest short interest is 1.82M, so 2.94% of the outstanding shares have been sold short.
| Short Interest | 1.82M |
| Short % of Shares Out | 2.94% |
| Short % of Float | 3.99% |
| Short Ratio (days to cover) | 12.46 |
Valuation Ratios
The PE ratio is -0.53 and the forward PE ratio is -0.43. Passage Bio's PEG ratio is 0.01.
| PE Ratio | -0.53 |
| Forward PE | -0.43 |
| PS Ratio | 0 |
| Forward PS | 0 |
| PB Ratio | 0.56 |
| P/FCF Ratio | -0.71 |
| PEG Ratio | 0.01 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Passage Bio.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.07, with a Debt / Equity ratio of 0.42.
| Current Ratio | 4.07 |
| Quick Ratio | 4.07 |
| Debt / Equity | 0.42 |
| Debt / EBITDA | -0.36 |
| Debt / FCF | -0.53 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-1,079,450 |
| Employee Count | 60 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -73.88% in the last 52 weeks. The beta is 1.59, so Passage Bio's price volatility has been higher than the market average.
| Beta | 1.59 |
| 52-Week Price Change | -73.88% |
| 50-Day Moving Average | 0.41 |
| 200-Day Moving Average | 0.62 |
| Relative Strength Index (RSI) | 43.49 |
| Average Volume (20 Days) | 171,439 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -70.4M |
| Net Income | -64.77M |
| EBITDA | -70.4M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -1.07 |
Balance Sheet
The company has 37.57M in cash and 25.48M in debt, giving a net cash position of 12.1M.
| Cash & Cash Equivalents | 37.57M |
| Total Debt | 25.48M |
| Net Cash | 12.1M |
| Retained Earnings | -659.24M |
| Total Assets | 102.41M |
| Working Capital | 59.45M |
Cash Flow
In the last 12 months, operating cash flow was -47.96M and capital expenditures -34K, giving a free cash flow of -47.99M.
| Operating Cash Flow | -47.96M |
| Capital Expenditures | -34K |
| Free Cash Flow | -47.99M |
| FCF Per Share | -0.79 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PASG does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for PASG is $6, which is 1614.3% higher than the current price. The consensus rating is "Buy".
| Price Target | $6 |
| Price Target Difference | 1614.3% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
Scores
| Altman Z-Score | -10.13 |
| Piotroski F-Score | 1 |